Apceth GmbH & Co. KG
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101 (NCT02008539) | Apceth GmbH & Co. KG | 2013-10-01 |
| Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia (NCT01351610) | Apceth GmbH & Co. KG | 2011-03-01 |
Track Apceth GmbH & Co. KG automatically
Every clearance here is in the API, with alerts when new ones post.